New research reveals that the greatest demand for liver transplantation due to hepatitis C (HCV)-related liver disease occurs among Americans born between 1941 and 1960. Findings in the December issue of Liver Transplantation, ...
Dec 6, 2012
0
0
Combination therapies for AIDS are becoming increasingly effective, but they cannot protect against other sexually transmitted illnesses. It is unsafe for patients taking antiretroviral drugs to stop using condoms. This is ...
Nov 30, 2012
0
0
When you get an acute infection, such as influenza, the body generally responds with a coordinated response of immune-cell proliferation and attack that rapidly clears the pathogen. Then, their mission done, the immune system ...
Nov 29, 2012
0
0
(HealthDay)—A U.S. task force suggests that people at high risk for the hepatitis C virus should be screened, which includes those with a history of intravenous drug use and those who received blood transfusions before ...
Nov 26, 2012
0
0
(Medical Xpress)—The adverse side effects of certain hepatitis C medications can now be replicated and observed in Petri dishes and test tubes, thanks to a research team led by Craig Cameron, the Paul Berg Professor of ...
Nov 16, 2012
0
0
an issue in most prisons in Canada and other parts of the world—negatively impacts the mental and physical health of prisoners, states an article in CMAJ (Canadian Medical Association Journal).
Nov 5, 2012
0
0
(AP)—A New Hampshire judge says a hospital tied to a hepatitis C outbreak must grant public health officials broad access to patient records.
Nov 2, 2012
0
0
A new study shows that African American women coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) are less likely to die from liver disease than Caucasian or Hispanic women. Findings in the November ...
Nov 1, 2012
0
0
Stanford University School of Medicine scientists have used bioengineered mice with livers composed largely of human cells to characterize a drug about to enter early-stage clinical development for combating hepatitis C.
Oct 31, 2012
0
0
Treating chronic hepatitis C infection with antiviral drugs could halve the risk of developing the most common form of liver cancer, in some cases, indicates an analysis of the published research in one of the new BMJ Open ...
Oct 22, 2012
0
0
